Compounds > technetium tc 99m diphosphonate
Page last updated: 2024-09-04

technetium tc 99m diphosphonate and Prostatic Neoplasms

technetium tc 99m diphosphonate has been researched along with Prostatic Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mochtar, CA; Sanjaya, IP; Umbas, R1
Muroff, LR1
Langhammer, H; Pabst, HW; Schmid, L; Sintermann, R1
Hawes, DR; Turner, JW; Williams, RD1
Kumanov, Kh; Mladenov, D; Petrov, T; Tsvetkov, M1
Castronovo, FP; Dann, J; McKusick, KA; Prout, GR; Strauss, HW1
Lundorf, E1

Reviews

1 review(s) available for technetium tc 99m diphosphonate and Prostatic Neoplasms

ArticleYear
Optimizing the performance and interpretation of bone scans.
    Clinical nuclear medicine, 1981, Volume: 6, Issue:10S

    Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Carcinoma; Diphosphates; Diphosphonates; Fractures, Bone; Humans; Lung Neoplasms; Male; Osteomyelitis; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate

1981

Other Studies

6 other study(ies) available for technetium tc 99m diphosphonate and Prostatic Neoplasms

ArticleYear
Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:9

    Topics: Aged; Bone and Bones; Bone Neoplasms; Cohort Studies; Diphosphonates; Humans; Indonesia; Kallikreins; Male; Middle Aged; Neoplasm Grading; Patient Selection; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Compounds

2013
[Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1981, Volume: 135, Issue:1

    Topics: Antineoplastic Agents; Bone Neoplasms; Castration; Diphosphates; Diphosphonates; Estrogens; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds; Technetium Tc 99m Pyrophosphate

1981
Magnetic resonance imaging for detection of prostate cancer metastatic to bone.
    The Journal of urology, 1993, Volume: 149, Issue:6

    Topics: Bone and Bones; Bone Neoplasms; Diphosphonates; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds

1993
[The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Khirurgiia, 1991, Volume: 44, Issue:5

    Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma; Diphosphonates; Humans; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds; Time Factors; Whole-Body Counting

1991
A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP).
    International journal of nuclear medicine and biology, 1985, Volume: 12, Issue:3

    Topics: Bone Neoplasms; Diphosphonates; Humans; Kinetics; Male; Prostatic Neoplasms; Technetium; Technetium Compounds; Time Factors; Tissue Distribution; Tomography, Emission-Computed

1985
[Superscan].
    Ugeskrift for laeger, 1985, Jan-14, Volume: 147, Issue:3

    Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds

1985